STAT June 18, 2024
Casey Ross

Republican lawmakers are sharply criticizing the Food and Drug Administration’s relationship with a nonprofit group seeking to create a network of laboratories to test artificial intelligence products used in health care.

In a letter sent Tuesday, the lawmakers asserted that the agency’s budding partnership with the nonprofit Coalition for Health AI (CHAI) will embed a “clear conflict...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Congress / White House, FDA, Govt Agencies, Partnerships, Technology, Trends
FDA warns GLP-1 compounder over safety rules
GLP-1 drug approvals: A breakdown
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Certainty vs. speed: How do patients feel about the tradeoff for new cancer drugs?

Share This Article